Surmodics | SRDX - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.13B 1.3B 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Anika Therapeutics USD 143.46M 3.34M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Artivion USD 448.23M 9.54M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
EDAP TMS EUR 23.32M 4.5M 2025-09
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Haemonetics USD 911.45M 62.28M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
J&J USD 78.47B 0 2025-09
Merit Medical Systems USD 1.58B 54.9M 2025-12
Mesa Laboratories USD 186.69M 8.22M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Option Care Health USD 1.33B 32.27M 2025-12
Stryker USD 21.78B 594M 2025-09
Surmodics USD 111.31M 7.59M 2025-06
Trinity Biotech USD -54.72M 5.18M 2025-09